- A dictionary of medical eponyms

Rebecca Craighill Lancefield - bibliography

Related eponyms

Biography

American bacteriologist, born January 5, 1895, fort Wadsworth, Staten Island, New York; died March 3, 1981.

Bibliography

  • R. Dochez, O. T. Avery and R. C. Lancefield:
    Studies on the biology of streptococcus. I. Antigenic relationship between strains of Streptococcus haemolyticus.
    The Journal of Experimental Medicine, New York, 1919, 30:179-213.
  • R. C. Lancefield and C. W. Metz:
    Non-disjunction and the chromosome relationship of Drosophila willistoni. Proceedings of the National Academy of Sciences of the United States of America. 1921, 7: 225-229.
  • R. C. Lancefield and C. W. Metz:
    The sex-linked group of mutant characters in Drosophila willistoni.
    Am Nat, 1922, 36: 211-241.
  • R. C. Lancefield:
    Antigenic relationships of the nucleo-proteins from the gram-positive cocci. (Abstract)
    Proceedings of the Society for Experimental Biology and Medicine, New York, 1924, 22: 109-111.
  • R. C. Lancefield:
    The immunological relationships of Streptococcus viridans and certain of its chemical fractions. I. Serological reactions obtained with anti-bacterial sera.
    The Journal of Experimental Medicine, 1925, 42: 377-395.
  • R. C. Lancefield:
    The immunological relationships of Streptococcus viridans and certain of its chemical fractions. II. Serological reactions obtained with anti-nucleoprotein sera.
    The Journal of Experimental Medicine, 1925, 42: 397-412.
  • R. C. Lancefield:
    The antigenic complex of Streptococcus haemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus.
    The Journal of Experimental Medicine, 1928, 47: 91-103.
  • R. C. Lancefield:
    The antigenic complex of Streptococcus haemolyticus. II. Chemical and immunological properties of the protein fractions.
    The Journal of Experimental Medicine, 1928, 47: 469-480.
  • R. C. Lancefield:
    The antigenic complex of Streptococcus haemolyticus. III. Chemical and immunological properties of the species-specific substance.
    The Journal of Experimental Medicine, 1928, 47: 481-491.
  • R. C. Lancefield:
    The antigenic complex of Streptococcus haemolyticus. IV. Anaphylaxis with two non-type specific fractions.
    The Journal of Experimental Medicine, 1928, 47: 843-855.
  • R. C. Lancefield:
    The antigenic complex of Streptococcus haemolyticus. V. Anaphylaxis with the type-specific substance. The Journal of Experimental Medicine, 1928, 47: 857-875.
  • E. W. Todd and R. C. Lancefield:
    Variants of hemolytic streptococci; their relation to type-specific substance, virulence, and toxin. The Journal of Experimental Medicine, 1928, 48:751-761.
  • R. C. Lancefield and E. W. Todd:
    Antigenic differences between matt hemolytic streptococci and their glossy variants.
    The Journal of Experimental Medicine, 1928, 48: 769-790.
  • R. C. Lancefield:
    Note on the susceptibility of certain strains of hemolytic streptococcus to a streptococcus bacteriophage.
    Proceedings of the Society for Experimental Biology and Medicine, 1932, 30: 169.
  • R. C. Lancefield:
    A serological differentiation of human and other groups of hemolytic streptococci.
    The Journal of Experimental Medicine, 1933, 57: 571-595.
  • R. C. Lancefield:
    A serological differentiation of specific types of bovine hemolytic streptococci (Group B).
    The Journal of Experimental Medicine, 1934, 59: 441-458.
  • R. C. Lancefield:
    Loss of the properties of hemolysin and pigment formation without change in immunological specificity in a strain of Streptococcus haemolyticus.
    The Journal of Experimental Medicine, 1934 59: 459-469.
  • R. Goodner, R. C. Lancefield, and H. F. Swift:
    The serological classification of hemolytic streptococci in relation to epidemiological problems.
    The American Journal of the Medical Sciences, 1935, 190: 445-453. (Review)
  • R. C. Lancefield and R. Hare:
    The serological differentiation of pathogenic and non-pathogenic streptococci from parturient women. The Journal of Experimental Medicine, 1935, 61: 335.349.
  • R. C. Lancefield and H. F. Swift:
    The problem of serological classification of haemolytic streptococci.
    Proceedings of the 2nd International Congress for Microbiology, 25 July-01 August, 1936, London, pp. 1936-1937. (Abstract)
  • R. C. Lancefield:
    Two serological types of group B hemolytic streptococci with related, but not identical, type-specific substances.
    The Journal of Experimental Medicine, 1938, 67: 25-40.
  • R. C. Lancefield:
    A micro-precipitin technic for classifying hemolytic streptococci, and improved methods for producing antisera. Proceedings of the Society for Experimental Biology and Medicine, 1938, 38: 473-478.
  • G. K. Hirst and R. C. Lancefield:
    Antigenic properties of the type-specific substance derived from group A hemolytic streptococci. The Journal of Experimental Medicine, 1939, 69: 425-445.
  • R. C. Lancefield:
    Type-specific antigens, M and T, of matt and glossy variants of group A hemolytic streptococci.
    The Journal of Experimental Medicine, 1940, 71: 521-537.
  • R. C. Lancefield:
    The significance of M and T antigens in the cross reactions between certain types of group A hemolytic streptococci.
    The Journal of Experimental Medicine, 1940, 71: 539-550.
  • R. C. Lancefield:
    Specific relationship of cell composition to biological activity of hemolytic streptococci. Harvey Lectures 1941, 36: 251.
  • H. F. Swift, A. T. Wilson, and R. C. Lancefield:
    Typing group A hemolytic streptococci by M precipitin reaction in capillary pipettes.
    The Journal of Experimental Medicine, 1943, 78: 127133.
  • R. C. Lancefield:
    Studies on the antigenic composition of group A hemolytic streptococci. I. Effects of proteolytic enzymes on streptococcal cells.
    The Journal of Experimental Medicine, 1943, 78: 465476.
  • R. C. Lancefield and W. A. Stewart:
    Studies on the antigenic composition of group A hemolytic streptococci. II. The occurrence of strains in a given type containing M but no T antigen.
    The Journal of Experimental Medicine, 1944, 79: 79-88.
  • R. C. Lancefield and R. F. Watson:
    Studies on the antigenic composition of group A hemolytic streptococci. III. Types with serologically identical M but distinct T antigens types 10 and 12.
    The Journal of Experimental Medicine, 1944, 79: 89-98.
  • R. C. Lancefield, W. A. Stewart, A. T. Wilson and H. F. Swift:
    Studies on the antigenic composition of group A hemolytic streptococci. IV. Related T but distinct M antigens in types 15, 17, 23, 30 and in types 4, 24, 26, 28, 29 and 46. Identification by slide agglutination.
    The Journal of Experimental Medicine, 1944, 79: 99-114.
  • R. C. Lancefield and H. F. Swift:
    Comparison of methods for capillary pipette typing of group A hemolytic streptococci. AAF News Letter, 1945, 2: 25.
  • R. C. Lancefield and V. P. Dole:
    The properties of T antigens extracted from group A hemolytic streptococci.
    The Journal of Experimental Medicine, 1946, 84: 449-470.
  • R. C. Lancefield and G. E. Perlmann:
    Preparation and properties of type-specific M antigen isolated from a group A, type I, hemolytic streptococcus.
    The Journal of Experimental Medicine, 1952, 96: 72-82.
  • R. C. Lancefield and G. E. Perlmann:
    Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups.
    The Journal of Experimental Medicine, 1952, 96: 83-97.
  • R. C. Lancefield:
    Cellular constituents of group A streptococci concerned in antigenicity and virulence.
    In: Streptococcal Infections, edited by M. McCarty, pp. 3-18. New York: Columbia University Press, 1954.
  • M. McCarty and R. C. Lancefield:
    Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.
    The Journal of Experimental Medicine, 1955, 102: 11-28.
  • R. C. Lancefield:
    Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.
    The Journal of Experimental Medicine, 1957, 106: 525-544..
  • R. C. Lancefield:
    Occurrence of R antigen specific for group A type 3 streptococci.
    The Journal of Experimental Medicine, 1958, 108:329-544.
  • R. C. Lancefield:
    Persistence of type specific antibodies in man following infection with group A streptococci.
    The Journal of Experimental Medicine, 1959, 110: 271-292.
  • E. W. Hook, R. R. Wagner, and R. C. Lancefield:
    An epizootic in Swiss mice caused by a group A streptococcus, newly designated type 50.
    The American Journal of Hygiene, Baltimore, 1960, 72:111-119.
  • R. F. Watson, G. K. Hirst, and R. C. Lancefield:
    Bacteriological studies of cardiac tissues obtained at autopsy from eleven patients dying with rheumatic fever. Arthritis and Rheumatism, 1961, 4: 74.
  • R. C. Lancefield:
    Current knowledge of type specific M antigens of group A streptococci.
    The Journal of Immunology, 1962, 89: 307-313.
  • W. F. Schneider, S. Chapman, V. Schulz, R. M. Krause, and R. C. Lancefield:
    Prevention of streptococcal pharyngitis among military personnel and their civilian dependents by mass prophylaxis.
    The New England Journal of Medicine, Boston, 1964, 270: 1205.
  • R. C. Lancefield and E. H. Freimer:
    Type-specific polysaccharide antigens of group B streptococci.
    The Journal of Hygiene, Cambridge, UK, 1964, 64: 191-202.
  • R. C. Lancefield:
    Current problems in studies of streptococci. (2nd Griffith Memorial Lecture)
    The Journal of General Microbiology, London, 1970, 55:161.
  • Kuttner and R. C. Lancefield:
    Unsolved problems of the non-suppurative complications of group A streptococcal infections.
    In: Infectious Agents and Host Reactions, edited by Stuart Mudd, pp. 174-196. Philadelphia: W.B. Saunders Co., 1970.
  • R. C. Lancefield, J. Rotta, R. M. Krause, W. Everly and H. Lackland:
    New approaches for the laboratory recognition of M types of group A strptococci.
    The Journal of Experimental Medicine, 1971, 134: 1298-1315.
  • R. C. Lancefield, M. McCarty and W. Everly:
    Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
    The Journal of Experimental Medicine, 1975, 142: 165-179.
  • R. C. Lancefield, S. D. Elliott and M. McCarty:
    Teichoic acids of group D streptococci with special reference to strain from pig meningitis (Streptococcus suis).
    The Journal of Experimental Medicine, 1977, 145: 490-499.
  • R. C. Lancefield, J. Y. Tai and E. C. Gotschlich:
    Isolation of type-soecific polusaccharide antigen from group B type Ib streptococci.
    The Journal of Experimental Medicine, 1979, 149: 58-66.
  • Elizabeth M. O'Hern:
    Rebecca Craighill Lancefield, Pioneer Microbiologist.
    National Institute of General Medical Sciences, Bethesda, Maryland 20014.
  • Maclyn McCarty:
    Rebecca Creighill Lancefield. January 5, 1895–March 3, 1981.
    Biographical memoirs, 1987, 57: 226-246.

What is an eponym?

An eponym is a word derived from the name of a person, whether real or fictional. A medical eponym is thus any word related to medicine, whose name is derived from a person.

What is Whonamedit?

Whonamedit.com is a biographical dictionary of medical eponyms. It is our ambition to present a complete survey of all medical phenomena named for a person, with a biography of that person.

Disclaimer:

Whonamedit? does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.